Hansen Medical (HNSN) Announces FDA Clearance for CoHesion(TM) Module
More News related to HNSN
- Hansen Medical to Present at the Merriman Curhan Ford 5th Annual Investor Summit 2008
- Hansen Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference
- Hansen Medical Announces World's First Robotic Transvascular Aneurysm Repair
- Hansen Medical to Present at the Thomas Weisel Partners Healthcare Conference 2008
- Pre-Open Movers 8/01: Boyd Gaming (BYD) Higher On Results/Project Delay; Elan (ELN)/Biogen (BIIB) Slammed On More TYSABRI PML Issues
Hansen Medical (NASDAQ: HNSN) has received FDA 510(k) clearance to market the CoHesion(TM) 3D Visualization Module for use in complex electrophysiology (EP) mapping procedures. This integrated EP solution offers a software interface between the Hansen Medical Sensei(TM) Robotic Catheter system and the EnSite(TM) System advanced mapping software from St. Jude Medical, Inc. Hansen Medical's platform solution offers physicians the ability to instinctively navigate a catheter during the diagnostic phase of a complex cardiac arrhythmia procedure. The new CoHesion module imports the EnSite System's 3D cardiac chamber model with anatomic labeling into the Sensei system's main navigation window, allowing physicians to see the location of Hansen Medical's Artisan(TM) Control Catheters within the heart in 3D.
Related Categories
Corporate NewsFDA
Stocks Mentioned
-0.41Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
